Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center

Clinical research site in Nashville, Tennessee · 1215 21ST AVE S, SUITE 9302, NASHVILLE, TN 37232-0014 · (615) 343-6152

Part of Vanderbilt

As of July 2026, 23 paid clinical trials are recruiting at Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center in Nashville, Tennessee. Active studies at this site cover conditions such as Glycogen Storage Disease Type II, Pompe Disease and Fabry Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center (23)

Pompe Disease Registry Protocol

for Glycogen Storage Disease Type II

74 locations incl. Birmingham

Sponsor: Genzyme, a Sanofi Company

Sex: All·Age: All ages

Code: NCT00231400·Recruiting·Listed Oct 2005

Apply to this trial

Fabry Disease Registry & Pregnancy Sub-registry

for Fabry Disease

74 locations incl. Birmingham

Sponsor: Genzyme, a Sanofi Company

Sex: All·Age: All ages

Code: NCT00196742·Recruiting·Listed Sep 2005

Apply to this trial

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

for Agitation

43 locations incl. Homewood

Sponsor: Celgene

Sex: All·Age: 55 - 90

Code: NCT06808984·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

for Non-small Cell Lung Cancer

39 locations incl. Birmingham

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06712316·Phase 2, Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

for Idiopathic Inflammatory Myopathy

31 locations incl. Orange

Sponsor: Cabaletta Bio

Sex: All·Age: 6 - 75

Code: NCT06154252·Phase 2, Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for Gaucher Disease

70 locations incl. Phoenix

Sponsor: Genzyme, a Sanofi Company

Sex: All·Age: All ages

Code: NCT00358943·Recruiting·Listed Aug 2006

Apply to this trial

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

for Diabetic Foot Ulcer

26 locations incl. Mesa

Sponsor: Piomic Medical

Sex: All·Age: 22 - 90

Code: NCT05758545·Recruiting·Listed Mar 2023

Apply to this trial

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

for MASH - Metabolic Dysfunction-Associated Steatohepatitis

16 locations incl. La Jolla

Sponsor: Madrigal Pharmaceuticals, Inc.

Sex: All·Age: 18 - 75

Code: NCT07335601·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for Huntington Disease

21 locations incl. La Jolla

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 21 - 70

Code: NCT07326709·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

for Generalized Myasthenia Gravis

15 locations incl. Scottsdale

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT06517758·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for Osteogenesis Imperfecta (OI)

9 locations incl. Phoenix

Sponsor: Angitia Incorporated Limited

Sex: All·Age: 18 - 75

Code: NCT07062588·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

for Hypothalamic Obesity

6 locations incl. Birmingham

Sponsor: Rhythm Pharmaceuticals, Inc.

Sex: All·Age: 12 - 65·Accepts healthy volunteers

Code: NCT06239116·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)

for Frontotemporal Dementia

3 locations incl. Columbus

Sponsor: AviadoBio Ltd

Sex: All·Age: 30 - 75

Code: NCT06064890·Phase 1, Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)

for Acute Uncomplicated Diverticulitis

1 location in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18 - 90

Code: NCT07492134·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Vanderbilt Integrated Community TMS for Opioid Recovery

for Opiod Use Disorder

2 locations incl. Brentwood

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18 - 65

Code: NCT07457489·Recruiting·Listed Mar 2026

Apply to this trial

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for Myopia

17 locations incl. Birmingham

Sponsor: Jaeb Center for Health Research

Sex: All·Age: 5 - 11

Code: NCT07095894·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

for Down Syndrome

1 location in Nashville

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT05231798·Phase 2·Recruiting·Listed Feb 2022

Apply to this trial

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

for Diabetes Mellitus

3 locations incl. Manchester

Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All·Age: 18+

Code: NCT05955339·Recruiting·Listed Jul 2023

Apply to this trial

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

for Lung Transplant

11 locations incl. Los Angeles

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 12+

Code: NCT06476132·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

for Amblyopia

68 locations incl. Birmingham

Sponsor: Jaeb Center for Health Research

Sex: All·Age: 3 - 13

Code: NCT04378790·Phase 3·Recruiting·Listed May 2020

Apply to this trial

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

for Congenital Diaphragmatic Hernia

19 locations incl. Birmingham

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 0 Months - 1 Month

Code: NCT05213676·Phase 4·Recruiting·Listed Jan 2022

Apply to this trial

CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease

for End Stage Renal Disease

2 locations incl. Sacramento

Sponsor: Vanderbilt University Medical Center

Sex: All·Age: 18 - 75

Code: NCT05422534·Phase 3·Recruiting·Listed Jun 2022

Apply to this trial

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

for Diabetes

3 locations incl. Manchester

Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All·Age: 65+

Code: NCT05824572·Recruiting·Listed Apr 2023

Apply to this trial

More research sites in Nashville

Vanderbilt University Medical Center (369 trials)
SCRI Oncology Partners (127 trials)
Vanderbilt University/Ingram Cancer Center (86 trials)
Sarah Cannon Research Institute (62 trials)
Vanderbilt University (55 trials)
Tennessee Oncology (48 trials)
Vanderbilt-Ingram Cancer Center (39 trials)
The Children's Hospital at TriStar Centennial (28 trials)
Monroe Carell Jr. Children's Hospital at Vanderbilt (13 trials)
Tennessee Oncology, PLLC (13 trials)

Explore more

Paid clinical trials in Nashville, TN · Tennessee clinical trials